Arbutus Biopharma Corp.

From Arbutus Biopharma's results release of 10 Kasım 2026; its quarterly report has since been filed.

• Revenue

  Actual

  $299K

  -%43 y/y ↓
  -%71 q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  $0,30

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -$10,5M

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.